{"id":5333,"date":"2023-08-09T11:08:05","date_gmt":"2023-08-09T10:08:05","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=5333"},"modified":"2024-06-03T11:42:23","modified_gmt":"2024-06-03T10:42:23","slug":"drug-hiv-treatment-authorized-biweekly-therapeutic-report","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/","title":{"rendered":"Drug for HIV Treatment Authorized in Therapeutic Extension"},"content":{"rendered":"<\/p>\n

The Federal Commission for Protection against Health Risks<\/span> (Cofepris)<\/span> reports that, according to the latest biweekly report on therapeutic extensions, 149 healthcare inputs have been authorized in the categories of drugs, medical devices and clinical trials.<\/span><\/p>\n

In the report for the first half of June, 25 drugs were authorized, including efavirenz\/lamivudine\/tenofovir disoproxil fumarate, a new molecule for the treatment of HIV, and L-asparaginase, a biotech for acute lymphoid leukemia.<\/span><\/p>\n

In addition, 116 new medical devices were registered, of which 21 are for medical care, including: hearing aids; a closed wound drainage system; an osteosynthesis plate and screw system; and total knee and shoulder replacements. In addition, 35 are medical equipment, including a subdural anesthesia kit; blood glucose meters; a flexible videolaryngoscope; and hip replacement instruments. Finally, 60 are intended to measure glycated hemoglobin, liver function, hormones, copper, zinc, p24 antigen for the detection of HIV, tetanus toxin, trypanosoma cruzi, and rheumatoid actor, among others. Read more about it here<\/a><\/span><\/p>\n

If you need more information on drug regulatory issues ELS can certainly help you with our registration services for your products<\/span><\/p>\n

Please contact your ELS local consultant <\/span><\/a>or through the email: info@elssolutions.pt<\/span><\/a><\/p>\n

\n","protected":false},"excerpt":{"rendered":"

149 new health products were approved: 25 drugs, 116 medical devices and eight clinical trials.<\/p>\n","protected":false},"author":9,"featured_media":5479,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[54,61],"tags":[62],"class_list":["post-5333","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-news","tag-news"],"yoast_head":"\nHIV Treatment Drug Authorized in Therapeutic Extension<\/title>\n<meta name=\"description\" content=\"Latest report informs that 149 healthcare inputs have been authorized: 25 drugs, 116 medical devices and eight clinical trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The drug for HIV treatment was authorized in new biweekly therapeutic extension report\" \/>\n<meta property=\"og:description\" content=\"149 new health products were approved: 25 drugs, 116 medical devices and eight clinical trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-09T10:08:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-03T10:42:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Drug for HIV Treatment Authorized in Therapeutic Extension\",\"datePublished\":\"2023-08-09T10:08:05+00:00\",\"dateModified\":\"2024-06-03T10:42:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/\"},\"wordCount\":920,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg\",\"keywords\":[\"News\"],\"articleSection\":[\"General\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/\",\"url\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/\",\"name\":\"HIV Treatment Drug Authorized in Therapeutic Extension\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg\",\"datePublished\":\"2023-08-09T10:08:05+00:00\",\"dateModified\":\"2024-06-03T10:42:23+00:00\",\"description\":\"Latest report informs that 149 healthcare inputs have been authorized: 25 drugs, 116 medical devices and eight clinical trials.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Medicamento para tratamento HIV foi autorizado no relat\u00f3rio quinzenal de extens\u00e3o terap\u00eautica\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug for HIV Treatment Authorized in Therapeutic Extension\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HIV Treatment Drug Authorized in Therapeutic Extension","description":"Latest report informs that 149 healthcare inputs have been authorized: 25 drugs, 116 medical devices and eight clinical trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/","og_locale":"en_US","og_type":"article","og_title":"The drug for HIV treatment was authorized in new biweekly therapeutic extension report","og_description":"149 new health products were approved: 25 drugs, 116 medical devices and eight clinical trials.","og_url":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2023-08-09T10:08:05+00:00","article_modified_time":"2024-06-03T10:42:23+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.png","type":"image\/png"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Drug for HIV Treatment Authorized in Therapeutic Extension","datePublished":"2023-08-09T10:08:05+00:00","dateModified":"2024-06-03T10:42:23+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/"},"wordCount":920,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg","keywords":["News"],"articleSection":["General","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/","url":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/","name":"HIV Treatment Drug Authorized in Therapeutic Extension","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg","datePublished":"2023-08-09T10:08:05+00:00","dateModified":"2024-06-03T10:42:23+00:00","description":"Latest report informs that 149 healthcare inputs have been authorized: 25 drugs, 116 medical devices and eight clinical trials.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg","width":1200,"height":600,"caption":"Medicamento para tratamento HIV foi autorizado no relat\u00f3rio quinzenal de extens\u00e3o terap\u00eautica"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/drug-hiv-treatment-authorized-biweekly-therapeutic-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Drug for HIV Treatment Authorized in Therapeutic Extension"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=5333"}],"version-history":[{"count":4,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5333\/revisions"}],"predecessor-version":[{"id":6547,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5333\/revisions\/6547"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/5479"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=5333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=5333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=5333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}